Huo, S. et al. Mechanochemical bond scission for the activation of drugs. Nat. Chem. 13, 131–139 (2021).
Chen, L., Nixon, R. & De Bo, G. Force-controlled release of small molecules with a rotaxane actuator. Nature 628, 320–325 (2024).
Rwei, A. Y. et al. Ultrasound-triggered local anaesthesia. Nat. Biomed. Eng. 1, 644–653 (2017).
Wang, J. B., Aryal, M., Zhong, Q., Vyas, D. B. & Airan, R. D. Noninvasive ultrasonic drug uncaging maps whole-brain functional networks. Neuron 100, 728–738.e7 (2018).
Boulatov, R. The liberating force of ultrasound. Nat. Chem. 13, 112–114 (2021).
Suslick, K. S. Sonochemistry. Science 247, 1439–1445 (1990).
Mirvakili, S. M. & Langer, R. Wireless on-demand drug delivery. Nat. Electron. 4, 464–477 (2021).
Sebesta, C. et al. Subsecond multichannel magnetic control of select neural circuits in freely moving flies. Nat. Mater. 21, 951–958 (2022).
Bhansali, D. et al. Nanotechnology for pain management: current and future therapeutic interventions. Nano Today 39, 101223 (2021).
Duan, X. et al. Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano 7, 5858–5869 (2013).
Deisseroth, K. Optogenetics: 10 years of microbial opsins in neuroscience. Nat. Neurosci. 18, 1213–1225 (2015).
Bar-Zion, A. et al. Acoustically triggered mechanotherapy using genetically encoded gas vesicles. Nat. Nanotechnol. 16, 1403–1412 (2021).
Wang, C. et al. Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity. Nat. Commun. 14, 3877 (2023).
Yao, Y. et al. Remote control of mechanochemical reactions under physiological conditions using biocompatible focused ultrasound. Proc. Natl Acad. Sci. USA 120, e2309822120 (2023).
Airan, R. D. et al. Noninvasive targeted transcranial neuromodulation via focused ultrasound gated drug release from nanoemulsions. Nano Lett. 17, 652–659 (2017).
Chen, H. & Hwang, J. H. Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors. J. Ther. Ultrasound 1, 10 (2013).
Kiessling, F. et al. Recent advances in molecular, multimodal and theranostic ultrasound imaging. Adv. Drug Deliv. Rev. 72, 15–27 (2014).
Shi, Z., Wu, J., Song, Q., Göstl, R. & Herrmann, A. Toward drug release using polymer mechanochemical disulfide scission. J. Am. Chem. Soc. 142, 14725–14732 (2020).
Cravotto, G., Gaudino, E. C. & Cintas, P. On the mechanochemical activation by ultrasound. Chem. Soc. Rev. 42, 7521–7534 (2013).
Huo, S. et al. Mechano-nanoswitches for ultrasound-controlled drug activation. Adv. Sci. 9, e2104696 (2022).
Ghanem, M. A. et al. The role of polymer mechanochemistry in responsive materials and additive manufacturing. Nat. Rev. Mater. 6, 84–98 (2021).
Akbulatov, S. et al. Experimentally realized mechanochemistry distinct from force-accelerated scission of loaded bonds. Science 357, 299–303 (2017).
Li, J., Nagamani, C. & Moore, J. S. Polymer mechanochemistry: from destructive to productive. Acc. Chem. Res. 48, 2181–2190 (2015).
Chen, Y., Mellot, G., van Luijk, D., Creton, C. & Sijbesma, R. P. Mechanochemical tools for polymer materials. Chem. Soc. Rev. 50, 4100–4140 (2021).
Wu, M.-X. & Yang, Y.-W. Metal–organic framework (MOF)-based drug/cargo delivery and cancer therapy. Adv. Mater. 29, 1606134 (2017).
Bhunia, S., Deo, K. A. & Gaharwar, A. K. 2D covalent organic frameworks for biomedical applications. Adv. Funct. Mater. 30, 2002046 (2020).
Lin, R.-B. et al. Multifunctional porous hydrogen-bonded organic framework materials. Chem. Soc. Rev. 48, 1362–1389 (2019).
Li, Y.-L. et al. Record complexity in the polycatenation of three porous hydrogen-bonded organic frameworks with stepwise adsorption behaviors. J. Am. Chem. Soc. 142, 7218–7224 (2020).
Wang, B. et al. A novel mesoporous hydrogen-bonded organic framework with high porosity and stability. Chem. Commun. 56, 66–69 (2019).
Yin, Q. et al. An ultra-robust and crystalline redeemable hydrogen-bonded organic framework for synergistic chemo-photodynamic therapy. Angew. Chem. 130, 7817–7822 (2018).
Zentner, C. A. et al. High surface area and Z′ in a thermally stable 8-fold polycatenated hydrogen-bonded framework. Chem. Commun. 51, 11642–11645 (2015).
Boesmans, W., Hao, M. M. & Vanden Berghe, P. Optogenetic and chemogenetic techniques for neurogastroenterology. Nat. Rev. Gastroenterol. Hepatol. 15, 21–38 (2018).
Gomez, J. L. et al. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine. Science 357, 503–507 (2017).
Alexander, G. M. et al. Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors. Neuron 63, 27–39 (2009).
Guettier, J.-M. et al. A chemical-genetic approach to study G protein regulation of β cell function in vivo. Proc. Natl Acad. Sci. USA 106, 19197–19202 (2009).
Rao, S. et al. Remotely controlled chemomagnetic modulation of targeted neural circuits. Nat. Nanotechnol. 14, 967–973 (2019).
Tye, K. M. et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 493, 537–541 (2013).
Meng, Y., Hynynen, K. & Lipsman, N. Applications of focused ultrasound in the brain: from thermoablation to drug delivery. Nat. Rev. Neurol. 17, 7–22 (2021).
Wang, W. et al. Ultrasound-triggered in situ photon emission for noninvasive optogenetics. J. Am. Chem. Soc. 145, 1097–1107 (2023).
Duque, M. et al. Sonogenetic control of mammalian cells using exogenous Transient Receptor Potential A1 channels. Nat. Commun. 13, 600 (2022).
Matsubara, T. et al. Author Correction: Remote control of neural function by X-ray-induced scintillation. Nat. Commun. 13, 1950 (2022).
Wu, X. et al. Tether-free photothermal deep-brain stimulation in freely behaving mice via wide-field illumination in the near-infrared-II window. Nat. Biomed. Eng. 6, 754–770 (2022).
Pawley, G. S. Unit-cell refinement from powder diffraction scans. J. Appl. Crystallogr. 14, 357–361 (1981).
Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. C 71, 3–8 (2015).
Sheldrick, G. M. SHELXT – integrated space-group and crystal-structure determination. Acta Crystallogr. A 71, 3–8 (2015).
Hübschle, C. B., Sheldrick, G. M. & Dittrich, B. ShelXle: a Qt graphical user interface for SHELXL. J. Appl. Crystallogr. 44, 1281–1284 (2011).
Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42, 339–341 (2009).
Kresse, G. & Hafner, J. Ab initio molecular dynamics for liquid metals. Phys. Rev. B 47, 558–561 (1993).
Kresse, G. & Joubert, D. From ultrasoft pseudopotentials to the projector augmented-wave method. Phys. Rev. B 59, 1758–1775 (1999).
Blöchl, P. E. Projector augmented-wave method. Phys. Rev. B 50, 17953–17979 (1994).
Grimme, S. Semiempirical GGA-type density functional constructed with a long-range dispersion correction. J. Comput. Chem. 27, 1787–1799 (2006).
Sundararaman, R. & Schwarz, K. Evaluating continuum solvation models for the electrode-electrolyte interface: challenges and strategies for improvement. J. Chem. Phys. 146, 084111 (2017).
Witten, I. B. et al. Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement. Neuron 72, 721–733 (2011).
Zan, G.-Y. et al. Amygdalar κ-opioid receptor-dependent upregulating glutamate transporter 1 mediates depressive-like behaviors of opioid abstinence. Cell Rep. 37, 109913 (2021).
Can, A. et al. The mouse forced swim test. J. Vis. Exp (59), 3638 (2012).
Airan, R. D., Thompson, K. R., Fenno, L. E., Bernstein, H. & Deisseroth, K. Temporally precise in vivo control of intracellular signalling. Nature 458, 1025–1029 (2009).
